Ryerson (NYSE:RYZ – Get Free Report) and Capstone Therapeutics (NASDAQ:CAPS – Get Free Report) are both small-cap industrials companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.
Risk and Volatility
Ryerson has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, Capstone Therapeutics has a beta of -1.5, suggesting that its share price is 250% less volatile than the S&P 500.
Earnings & Valuation
This table compares Ryerson and Capstone Therapeutics”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ryerson | $4.57 billion | 0.29 | -$56.40 million | ($1.24) | -20.44 |
| Capstone Therapeutics | $48.11 million | 0.08 | -$21.23 million | ($3.35) | -0.05 |
Capstone Therapeutics has lower revenue, but higher earnings than Ryerson. Ryerson is trading at a lower price-to-earnings ratio than Capstone Therapeutics, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for Ryerson and Capstone Therapeutics, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ryerson | 1 | 2 | 0 | 0 | 1.67 |
| Capstone Therapeutics | 1 | 0 | 0 | 0 | 1.00 |
Profitability
This table compares Ryerson and Capstone Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ryerson | -0.56% | -0.62% | -0.21% |
| Capstone Therapeutics | -36.51% | -144.43% | -40.48% |
Institutional and Insider Ownership
94.8% of Ryerson shares are held by institutional investors. Comparatively, 2.5% of Capstone Therapeutics shares are held by institutional investors. 6.6% of Ryerson shares are held by company insiders. Comparatively, 39.3% of Capstone Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Ryerson beats Capstone Therapeutics on 9 of the 12 factors compared between the two stocks.
About Ryerson
Ryerson Holding Corporation, together with its subsidiaries, processes and distributes industrial metals in the United States, Canada, Mexico, and China. It offers a line of products in carbon steel, stainless steel, alloy steels, and aluminum, as well as nickel and red metals in various shapes and forms, including coils, sheets, rounds, hexagons, square and flat bars, plates, structural, and tubing. The company also provides various processing services, such as bending, beveling, blanking, blasting, burning, cutting-to-length, drilling, embossing, flattening, forming, grinding, laser cutting, machining, notching, painting, perforating, polishing, punching, rolling, sawing, scribing, shearing, slitting, stamping, tapping, threading, welding, or other techniques to process materials. It serves various industries, including commercial ground transportation, metal fabrication and machine shops, industrial machinery and equipment manufacturing, consumer durable equipment, HVAC manufacturing, construction equipment manufacturing, food processing and agricultural equipment manufacturing, and oil and gas. The company was founded in 1842 and is headquartered in Chicago, Illinois.
About Capstone Therapeutics
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
Receive News & Ratings for Ryerson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryerson and related companies with MarketBeat.com's FREE daily email newsletter.
